Mark J. Arends

14.9k citations

193 papers · 9.8k indexed · 2 hit papers · h-index 51

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Oncology top 1%
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies

Papers in

Pathology and Forensic Medicine 58
- Genetic factors in colorectal cancer 53
Oncology 73
- Colorectal Cancer Treatments and Studies 21
- Cancer-related Molecular Pathways 17
- Colorectal Cancer Screening and Detection 15

Co-authors: Andrew H. Wyllie David J. Adams Gerry P. Crossan Ketan J. Patel Frédéric Langevin George Poulogiannis Ashraf E.K. Ibrahim Iván V. Rosado
Journals: The Journal of Pathology (22 papers)Oncogene (10 papers)Histopathology (6 papers)Journal of Clinical Pathology (6 papers)International Journal of Experimental Pathology (4 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Mark J. Arends

188 papers receiving 9.6k citations

Hit Papers

align trajectories log scale

CCPG1 Is a Non-canonical Autophagy Cargo Receptor Essential for ER-Phagy and Pancreatic ER Proteostasis 2017 · 341 citations

Peers

Countries citing papers authored by Mark J. Arends

Since Specialization

Citations

This map shows the geographic impact of Mark J. Arends's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Arends with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Arends more than expected).

Fields of papers citing papers by Mark J. Arends

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Arends. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Arends. The network helps show where Mark J. Arends may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark J. Arends, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark J. Arends Line = papers co-authored together Mark J. Arends links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comprehensive profiling of the mutational landscape of hidradenoma papilliferum validates key role of alterations in the phosphoinositide 3-kinase/AKT pathway British Journal of Dermatology ·Renato C. Iezzi, Louise van der Weyden, Kim Ping Wong, Martin Del Castillo Velasco‐Herrera, Aly Hanaa M, Ewen Chen, Elizabeth Anderson, Laura Allen, Nicolas de Saint Aubain, Laurita Denny, Ahmed Al‐Omari, Carolin Mogler, Carlos Monteagudo, A. Sheehan, Steven D. Billings, Mark J. Arends, Ingrid Ferreira, Thomas Brenn, David J. Adams	2025	1
2	Loss of DOCK2 potentiates Inflammatory Bowel Disease–associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expression Oncogene ·A. M. D. Churchhouse, Karen Hagi, Toshiyasu Suzuki, Sebastian Pohl, S Sottolano, Kevin Donnelly, Colin Nixon, Mark J. Arends, Shahida Din, P. Ducroux, 和郎高山, Alex von Kriegsheim, Seth B. Coffelt, Kevin Myant	2024	2
3	QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray Diagnostics ·Ross J Porter, Shahida Din, Peter Bankhead, Anca Oniscu, Mark J. Arends	2023	7
4	Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines Journal of Crohn s and Colitis ·Ross J Porter, Mark J. Arends, A. M. D. Churchhouse, Shahida Din	2021	80
5	Aldehyde-driven transcriptional stress triggers an anorexic DNA damage response Nature ·Lee Mulderrig, Juan I. Garaycoechea, Zewen Kelvin Tuong, Christopher L. Millington, Felix A. Dingler, John R. Ferdinand, Liam Gaul, John A. Tadross, Mark J. Arends, Stephen O’Rahilly, Gerry P. Crossan, Menna R. Clatworthy, Ketan J. Patel	2021	96
6	MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype Cancer Discovery ·Nicole M. Sodir, Roderik M. Kortlever, Valentin J.A. Barthet, V. Pochernyaev, Luca Pellegrinet, Christine A. Jones, Panayiotis Anastasiou, Lamorna Brown Swigart, Laura Soucek, Mark J. Arends, Trevor D. Littlewood, Gérard I. Evan	2020	123
7	Aspirin Rescues Wnt-Driven Stem-like Phenotype in Human Intestinal Organoids and Increases the Wnt Antagonist Dickkopf-1 Cellular and Molecular Gastroenterology and Hepatology ·Karen J. Dunbar, Asta Valančiūtė, G. F. R. B., McGarry Al, Thomas Jamieson, Huihua Yang, James P. Blackmur, 相原広子, Francyane Araújo Silva, Patrizia Cammareri, Mark J. Arends, Owen J. Sansom, Kevin Myant, Susan M. Farrington, Malcolm G. Dunlop, Farhat V N Din	2020	19
8	Diagnosis of digestive system tumours International Journal of Cancer ·M. Kay Washington, Richard M. Goldberg, George J. Chang, Paul J. Limburg, Alfred K. Lam, Manuel Salto‐Tellez, Mark J. Arends, Irıs D. Nagtegaal, David S. Klimstra, Massimo Rugge, Peter Schirmacher, Alexander J. Lazar, Robert D. Odze, Fátima Carneiro, Masashi Fukayama, Ian A. Cree, (unknown)	2020	34
9	Low‐contact and high‐interconnectivity pathology (LC&HI Path): post‐COVID19‐pandemic practice of pathology Histopathology ·Mark J. Arends, Manuel Salto‐Tellez	2020	5
10	Survey of UK histopathology consultants’ attitudes towards academic and molecular pathology Journal of Clinical Pathology ·Miaoran Chen, Caroline Young, Jessica Lee, Mark J. Arends, Bridget S. Wilkins, Gareth J. Thomas, Karin A. Oien, J. Louise Jones, Keith D. Hunter	2019	4
11	FBXO7 sensitivity of phenotypic traits elucidated by a hypomorphic allele PLoS ONE ·W. A. Bernhard, Simon Clare, Mark J. Arends, Emma L. Cambridge, Agnieszka Świątkowska, Susana Caetano, 张文木, Leanne Kane, Katherine Harcourt, David Goulding, Diane Gleeson, Edward J. Ryder, Brendan Doe, Jacqueline K. White, Louise van der Weyden, Gordon Dougan, David J. Adams, Anneliese O. Speak	2019	6
12	Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease–Associated Colorectal Cancers Clinical Cancer Research ·Shahida Din, Kim Wong, Cintia Ilze Chunga Mendoza, Anca Oniscu, James Hewinson, 利行山田, Martin L. Miller, Alejandro Jiménez-Sánchez, Roy Rabbie, S Trinca, Jack Satsangi, David J. Adams, Mark J. Arends	2018	27
13	A high-throughput in vivo screening method in the mouse for identifying regulators of metastatic colonization Nature Protocols ·Anneliese O. Speak, Agnieszka Świątkowska, Natasha A. Karp, Mark J. Arends, David J. Adams, Louise van der Weyden	2017	13
14	Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis Cancer Research ·Louise van der Weyden, Angelos Papaspyropoulos, George Poulogiannis, Alistair G. Rust, Mamunur Rashid, David J. Adams, Mark J. Arends, Eric O’Neill	2012	43
15	Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity Oncogene ·Louise van der Weyden, Alistair G. Rust, Rebecca E. McIntyre, Carla Daniela Robles‐Espinoza, Martin Del Castillo Velasco‐Herrera, Ruslan Strogantsev, Anne C. Ferguson‐Smith, Shane McCarthy, Thomas Keane, Mark J. Arends, David J. Adams	2012	19
16	38 Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome Leukemia Research ·Andrew J. Finch, Christine Hilcenko, Nicolas Basse, Lesley Drynan, Beatriz Goyenechea, Tobias Menne, Negishi Yuki, Paul J. Simpson, Clive S. D’Santos, Mark J. Arends, Jean Donadieu, Christine Bellanné‐Chantelot, Adrianna Mnich, Charles Boone, Andrew N. J. McKenzie, Stefan M.V. Freund, Alan J. Warren	2011	18
17	High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases Cellular Oncology ·Richard F. Hamm, Anaís Malpica, Thiago de Almeida Silvério, Einar Gudlaugsson, Emiel A. M. Janssen, Mark J. Arends, Arnold‐Jan Kruse, Yinhua Yu, Weiwei Feng, Jan P. Baak	2011	12
18	A novel immunohistochemical method to estimate cell‐cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer The Journal of Pathology ·Ian Scott, Lesley S. Morris, K Bird, R J Davies, Sarah L. Vowler, Simon Rushbrook, Aileen Marshall, Ronald A. Laskey, Richard N. Miller, Mark J. Arends, Nicholas Coleman	2003	77
19	Molecular characteristics of serrated adenomas of the colorectum Gut ·Elinor J. Sawyer, A. Cerar, A M Hanby, Patricia Gorman, Mark J. Arends, I C Talbot, Ian Tomlinson	2002	75
20	Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway Oncogene ·Pilar Esteve, Nieves Embade, Rosario Perona, Benilde Jiménez, Luis del Peso, Javier León, Mark J. Arends, Toru Miki, Juan Carlos Lacal	1998	88

About Mark J. Arends

Mark J. Arends is a scholar working on Pathology and Forensic Medicine, Oncology, Cancer Research, Reproductive Medicine and Molecular Biology, having authored 193 papers that have together received 9.8k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (53 papers), Cancer Genomics and Diagnostics (28 papers), Colorectal Cancer Treatments and Studies (21 papers), DNA Repair Mechanisms (20 papers), Cancer-related Molecular Pathways (17 papers), Colorectal Cancer Screening and Detection (15 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Epigenetics and DNA Methylation (12 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (2.5k citations), Pathology and Forensic Medicine (1.5k citations), Molecular Biology (5.4k citations) and Immunology (1.0k citations). Mark J. Arends has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Andrew H. Wyllie, David J. Adams, Gerry P. Crossan, Ketan J. Patel, Frédéric Langevin, George Poulogiannis, Ashraf E.K. Ibrahim, Iván V. Rosado, Ian M. Frayling and Mike F. Müller. Their work appears in journals such as The Journal of Pathology, Oncogene, Histopathology, Journal of Clinical Pathology and International Journal of Experimental Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact